Mirum Pharmaceuticals (MIRM) Shares Outstanding (Weighted Average) (2018 - 2026)

Mirum Pharmaceuticals' Shares Outstanding (Weighted Average) history runs 9 years deep, the most recent figure standing at $58.9 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) rose 20.38% year-over-year to $58.9 million; the TTM figure through Mar 2026 stood at $58.9 million (up 20.38% YoY), while the FY2025 annual figure was $50.2 million, up 5.63% from the prior year.
• Shares Outstanding (Weighted Average) was $58.9 million for Q1 2026 at Mirum Pharmaceuticals, up from $50.2 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $58.9 million in Q1 2026 to a low of $31.3 million in Q1 2022.
• Historically, Shares Outstanding (Weighted Average) has averaged $43.2 million across 5 years, with a median of $46.9 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Weighted Average) advanced 3.96% in 2022, then advanced 25.27% in 2023.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $33.8 million in 2022, then gained by 20.82% to $40.9 million in 2023, then climbed by 16.23% to $47.5 million in 2024, then climbed by 5.63% to $50.2 million in 2025, then climbed by 17.24% to $58.9 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $58.9 million (Q1 2026), $50.2 million (Q4 2025), and $49.8 million (Q3 2025), per Business Quant data.